Sign in
4

Changes in Ownership

Armata Pharmaceuticals, Inc. Filed Acc 0001104659-22-046440

Options or other derivatives

  • President and CEO acquired 240,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Varnum Brian President and CEO 2022-04-13 Grant or award · Stock Options (Right to Buy) +240,000 240,000 D
Loading xslF345X03/tm2212851-1_4seq1.xml…